Evidence map›Paper›PMID 31952228›Full record

ArticleMicromachines2020

Improving Single-Cell Encapsulation Efficiency and Reliability through Neutral Buoyancy of Suspension.

Hangrui Liu, Ming Li, Yan Wang, Jim Piper, Lianmei Jiang

Open access · goldAbstract read
In one paragraph

Article in Micromachines, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Article
  3. Periodic Flows in Microfluidics.Small (Weinheim an der Bergstrasse, Germany) · 2024
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Microencapsulation-based cell therapies.Cellular and molecular life sciences : CMLS · 2022
    Review
  12. Single-Cell Microgels for Diagnostics and Therapeutics.Advanced functional materials · 2021
    Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Hangrui LiuARC Centre of Excellence for Nanoscale BioPhotonics, Department of Physics and Astronomy, Macquarie University, Sydney, NSW 2109, Australia.
Ming LiSchool of Engineering, Macquarie University, Sydney, NSW 2122, Australia.
Yan WangARC Centre of Excellence for Nanoscale BioPhotonics, Department of Physics and Astronomy, Macquarie University, Sydney, NSW 2109, Australia.
Jim PiperARC Centre of Excellence for Nanoscale BioPhotonics, Department of Physics and Astronomy, Macquarie University, Sydney, NSW 2109, Australia.
Lianmei JiangARC Centre of Excellence for Nanoscale BioPhotonics, Department of Molecular Sciences, Macquarie University, Sydney, NSW 2109, Australia.
Macquarie University · AU

Funding

Australian Research Council (ARC) CE140100003
6 · The paper itself

Abstract

Single-cell analysis is of critical importance in revealing cell-to-cell heterogeneity by characterizing individual cells and identifying minority sub-populations of interest. Droplet-based microfluidics has been widely used in the past decade to achieve high-throughput single-cell analysis. However, to maximize the proportion of single-cell emulsification is challenging due to cell sedimentation and aggregation. The purpose of this study was to investigate the influence of single-cell encapsulation and incubation through the use of neutral buoyancy. As a proof of concept, OptiPrep™ was used to create neutrally buoyant cell suspensions of THP-1, a human monocytic leukemia cell line, for single-cell encapsulation and incubation. We found that using a neutrally buoyant suspension greatly increased the efficiency of single-cell encapsulation in microdroplets and eliminated unnecessary cell loss. Moreover, the presence of OptiPrep™ was shown to not affect cellular viability. This method significantly improved the effectiveness of single-cell study in a non-toxic environment and is expected to broadly facilitate single-cell analysis.

Indexed as

droplet microfluidicsencapsulation efficiencyneutral buoyancyOptiPrep™single-cell analysis

Identifiers

PMID31952228
PMCPMC7019761
OpenAlexW2999075452

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.